CLCN4 and glioblastoma: The findings showed that in the following tumor types: GBM, KIRC, LGG, OV, PCPG, SARC, TGCT, THCA, THYM, UCEC, and UCS, CLCN4 expression was adversely linked with the Immune-Score (Figure 6).